(Q42553454)

2 November 2017

title

Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma (English)

1 reference

2 November 2017

R C Dombrowski

1

1 reference

2 November 2017

J H Romeo

series ordinal

2

1 reference

2 November 2017

D C Aron

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

Annals of Pharmacotherapy

2 November 2017

published in

1 reference

2 November 2017

volume

29

1 reference

2 November 2017

issue

10

1 reference

2 November 2017

page(s)

999-1001

1 reference

Diagnostic work-up of hyperprolactinemic disorders

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901009

Hyperprolactinemia-galactorrhea induced by verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901009

Clinical and biochemical effects of verapamil administration to schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901009

Effects of verapamil on diurnal and thyrotropin-releasing hormone-stimulated prolactin levels in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901009

The pituitary "incidentaloma".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901009

Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901009

10.1177/106002809502901009

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference